AU2020236953A1 - Use of 8,9-dihydrocannabidiol compounds - Google Patents

Use of 8,9-dihydrocannabidiol compounds Download PDF

Info

Publication number
AU2020236953A1
AU2020236953A1 AU2020236953A AU2020236953A AU2020236953A1 AU 2020236953 A1 AU2020236953 A1 AU 2020236953A1 AU 2020236953 A AU2020236953 A AU 2020236953A AU 2020236953 A AU2020236953 A AU 2020236953A AU 2020236953 A1 AU2020236953 A1 AU 2020236953A1
Authority
AU
Australia
Prior art keywords
compound
alkyl
alkenyl
alkynyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020236953A
Other languages
English (en)
Inventor
Mark Mascal
Nikolay SHEVCHENKO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of AU2020236953A1 publication Critical patent/AU2020236953A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/26—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
AU2020236953A 2019-03-08 2020-03-09 Use of 8,9-dihydrocannabidiol compounds Abandoned AU2020236953A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815735P 2019-03-08 2019-03-08
US62/815,735 2019-03-08
PCT/US2020/021670 WO2020185661A1 (en) 2019-03-08 2020-03-09 Use of 8,9-dihydrocannabidiol compounds

Publications (1)

Publication Number Publication Date
AU2020236953A1 true AU2020236953A1 (en) 2021-09-30

Family

ID=72426794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020236953A Abandoned AU2020236953A1 (en) 2019-03-08 2020-03-09 Use of 8,9-dihydrocannabidiol compounds

Country Status (8)

Country Link
US (1) US20250152520A2 (https=)
EP (1) EP3935037A4 (https=)
JP (1) JP7620984B2 (https=)
CN (1) CN113874344B (https=)
AU (1) AU2020236953A1 (https=)
BR (1) BR112021017661A2 (https=)
CA (1) CA3132841A1 (https=)
WO (1) WO2020185661A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021150885A1 (en) * 2020-01-24 2021-07-29 Perkinelmer Health Sciences, Inc. Cannabinoid derivatives
CN114507153B (zh) * 2020-11-17 2025-06-24 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
CN113372196B (zh) * 2021-07-02 2022-09-30 江南大学 8,9-二氢大麻二酚及其合成方法与应用
WO2024006896A1 (en) * 2022-06-29 2024-01-04 The Regents Of The University Of California Uses of hydrogenated cannabidiol (h4cbd) and advanced metabolic syndrome
AU2024359022A1 (en) * 2023-10-10 2026-04-09 Jazz Pharmaceuticals Research Uk Limited Cannabinoid compounds and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018777A (en) * 1975-11-14 1977-04-19 Abbott Laboratories 2-Substituted-5-alkyl resorcinols
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
GB2530001B (en) * 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
CN108024973A (zh) * 2015-07-16 2018-05-11 耶路撒冷希伯来大学伊森姆研究发展有限公司 氟化的cbd化合物、其组合物以及用途
CN108785298A (zh) * 2017-04-27 2018-11-13 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途
CN109106699A (zh) * 2017-06-23 2019-01-01 汉义生物科技（北京）有限公司 一种用于治疗癫痫的药物组合物、其制备方法及用途

Also Published As

Publication number Publication date
US20250152520A2 (en) 2025-05-15
JP7620984B2 (ja) 2025-01-24
EP3935037A4 (en) 2023-03-22
BR112021017661A2 (pt) 2021-11-16
CN113874344B (zh) 2025-05-27
JP2022525038A (ja) 2022-05-11
US20220183998A1 (en) 2022-06-16
WO2020185661A1 (en) 2020-09-17
EP3935037A1 (en) 2022-01-12
CA3132841A1 (en) 2020-09-17
CN113874344A (zh) 2021-12-31

Similar Documents

Publication Publication Date Title
US20250152520A2 (en) Use of 8,9- dihydrocannabidiol compounds
US9162975B2 (en) Phenyl carbamate compounds for use in alleviating or treating pain
ES2881850T3 (es) Compuestos de carmato de fenil alquilo para su uso en la prevención o tratamiento de la epilepsia o síndrome relacionado con la epilepsia
US20240254072A1 (en) Derivatives of cannabidiol-c4 for the treatment of epilepsy
US9907776B2 (en) Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
US20260000641A1 (en) Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (imdai)
WO2023081897A1 (en) Isotopically enriched 3,4-methylenedioxy-n-ethylamphetamine (mde) and stereoisomers thereof
WO2025010308A2 (en) Mdma enantiomer compositions and methods for modulating aggression response
US5962523A (en) Methods of using butyric acid derivatives to protect against hair loss
US20250009766A1 (en) Cannabigerol for treatment of seizures and epilepsy
US9932302B1 (en) N-phenyl and N-benzyl enaminones and methods for using same

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application